Citrini Research Backs Life Sciences Stocks After Using Claude to Design Proteins
The firm designed 211 proteins with the AI model for lab testing, finding that 17 bound to scorpion toxins.
Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made
The story so far
2 publishers have covered this in 3 articles since 20 Oct 2026. Quartz published first, on 20 October at 14:01 UTC; Hacker News followed 3h 47m later. The most recent article, from Hacker News, appeared on 20 October at 17:48 UTC.
Outlets reporting it: Quartz, Hacker News.
No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.
How it unfolded
Every source in the order it published.
Sources
Every article we clustered into this story. Headlines link to the publisher.
- Citrini Research unterstützt Aktien im Bereich der Lebenswissenschaften, nachdem Claude verwendet wurde, um Proteine zu gestalten. Quartz
- Citrini Research is backing life sciences stocks after using Claude to design proteins Quartz
- Claude designed protein binders against scorpion neurotoxins Hacker News
In this story
- Citrini Research
- Claude